| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 01/04/2011 | US7862829 Enhance immunology response ti immunogen; alpha virus adjuvant or Venezuelan Equine Encephalatis virua adjuvants |
| 01/04/2011 | US7862810 Repairing damaged myocardium and/or myocardial cells utilizing differentiated cardiac stem cells; tissue engineering |
| 01/04/2011 | US7862809 Lactobacilic broth prevention or treatment of angiogenic disorders |
| 01/04/2011 | CA2573307C Use of platelet aggregation inhibitors |
| 01/04/2011 | CA2461691C Allograft bone composition having a gelatin binder |
| 01/04/2011 | CA2451184C Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and their use in bone marrow transplantation |
| 01/04/2011 | CA2411204C Composition and method |
| 01/04/2011 | CA2401545C Mutated cyclin g1 protein |
| 01/04/2011 | CA2388301C Modified gp100 and uses thereof |
| 01/04/2011 | CA2380777C Hepatitis c viral antigen immunoassay detection systems |
| 01/04/2011 | CA2350127C Avipox vector coding an hiv antigen and a cytokine |
| 01/04/2011 | CA2279474C Novel antibody composition for debulking blood and bone marrow samples from cml patients |
| 01/04/2011 | CA2268865C Anti-p53 single-chain antibody fragments and their uses |
| 01/04/2011 | CA2246744C Immunomodulatory complex and use thereof in diseases caused by helicobacter |
| 01/04/2011 | CA2231916C Erythrocytes loaded with s-nitrosothiol and uses therefor |
| 01/04/2011 | CA2163439C Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 01/04/2011 | CA2142575C Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma |
| 12/30/2010 | US20100333221 Mutated hyperthermophilic phosphotriesterases and uses thereof |
| 12/30/2010 | US20100331815 Transluminal delivery of oncoltyic viruses for cancer therapy |
| 12/30/2010 | US20100330673 Methods of making enhanced, autologous fat grafts |
| 12/30/2010 | US20100330192 Method for the prevention of chronic inflammation associated diseases |
| 12/30/2010 | US20100330182 Tendon Stem Cells |
| 12/30/2010 | US20100330159 System for transporting active substances in a biological system |
| 12/30/2010 | US20100330151 Method of Promoting Gastrointestinal Health Using a Combination of a Probiotic Microorganism and Chocolate |
| 12/30/2010 | US20100330135 Cosmetic composition |
| 12/30/2010 | US20100330128 Method of improving immune function in mammals using lactobacillus strains with certain lipids |
| 12/30/2010 | US20100330121 Recombinant alphavirus-based vectors with reduced inhibition of cellular macro-molecular synthesis |
| 12/30/2010 | US20100330057 Method of evaluating human dentritic cells and human cell immunotherapeutic agent |
| 12/30/2010 | US20100330056 Enhanced generation of cytotoxic t-lymphocytes by il-21 mediated foxp3 suppression |
| 12/30/2010 | US20100330054 Preparation, use of preparation for treatment, and method of treatment of intestinal infection |
| 12/30/2010 | US20100330053 Mixed-cell gene therapy |
| 12/30/2010 | US20100330052 Use of Mesenchymal Stem Cells for Treating Genetic Diseases and Disorders |
| 12/30/2010 | US20100330051 Polypeptide having an improved cytosine deaminase activity |
| 12/30/2010 | US20100330050 Use of human stem cells and/or factors they produce to promote adult mammalian cardiac repair through cardiomyocyte cell division |
| 12/30/2010 | US20100330049 Method for generating islet beta cells from dedifferentiated exocrine pancreatic cells |
| 12/30/2010 | US20100330048 Mesenchymal stem cells and uses therefor |
| 12/30/2010 | US20100330047 Mesenchymal Stem Cells Grown Under Hypoxic Conditions: Compositions, Methods and Uses Therefor |
| 12/30/2010 | US20100330046 Human skin substitutes expressing il-12 |
| 12/30/2010 | US20100330045 Mesenchymal precursor cell |
| 12/30/2010 | US20100330043 Gpr125 as a marker for stem and progenitor cells and methods use thereof |
| 12/30/2010 | US20100330042 Use of Proinsulin for the Preparation of a Neuroprotective Pharmaceutical Composition, Therapeutic Composition Containing it and Applications Thereof |
| 12/30/2010 | US20100330040 Composition with synbiotics |
| 12/30/2010 | US20100330039 Schizochytrium Fatty Acid Synthase (FAS) and Products and Methods Related Thereto |
| 12/30/2010 | US20100330038 Methods for expressing proteins in axons |
| 12/30/2010 | US20100330037 Adenoviral systems and the uses thereof |
| 12/30/2010 | US20100330036 Markers of matrix gene expression and cellular differentiation in chondrocytes |
| 12/30/2010 | US20100329986 Adult Hepatic Progenitor Cells and Methods of Use Thereof |
| 12/30/2010 | US20100329976 Nanoparticulate compositions of angiogenesis inhibitors |
| 12/29/2010 | WO2010151517A2 Antigen-specific long-term memory t-cells |
| 12/29/2010 | WO2010150650A1 Novel method for maintaining stem cells in an undifferentiated state |
| 12/29/2010 | WO2010149778A1 Fish protein hydrolysate for the use thereof in inhibiting weight gain and/or weight loss |
| 12/29/2010 | WO2010072327A3 Pharmaceutical composition based on peptide from camel milk |
| 12/29/2010 | EP2267445A1 Methods of detecting small intestinal bacterial overgrowth (SIBO) in a human subject |
| 12/29/2010 | EP2267120A1 Recombinant vaccinia virus having hepatitis c virus gene |
| 12/29/2010 | EP2267118A1 Method for production of transfected cell |
| 12/29/2010 | EP2267115A1 Anterior ocular segment related cell sheets, three-dimensional structures, and processes for producing the same |
| 12/29/2010 | EP2267112A1 Means and methods for preventing and/or treating caries |
| 12/29/2010 | EP2267026A1 Albumin fusion proteins |
| 12/29/2010 | EP2267004A2 Peptide derived from hepatitis C virus |
| 12/29/2010 | EP2266601A1 Administration of therapeutic viruses |
| 12/29/2010 | EP2266588A1 Method for cancer therapy based on co-administration of a parovirus and a cytokine |
| 12/29/2010 | EP2266587A1 Oncolytic virotherapy for prevention of tumor recurrence |
| 12/29/2010 | EP2266586A1 Compositions and method for alleviating inflammation and oxidative stress in a mammal |
| 12/29/2010 | EP2266543A2 Non-polymeric hematopoietic cell clots for delivery of active agents |
| 12/29/2010 | EP2266502A1 Apparatus for stenting with enhanced protection against embolism, restenosis and thrombus formation |
| 12/29/2010 | EP2266500A2 Three-dimensional tissue structure |
| 12/29/2010 | EP2266499A2 Three-dimensional tissue structure |
| 12/29/2010 | EP2266396A2 Modulation of stem cells using zinc finger proteins |
| 12/29/2010 | EP2265710A1 Human adipose derived insulin making mesenchymal stem cells for treating diabetes mellitus |
| 12/29/2010 | EP2265639A1 Compositions comprising antibodies or antibody fragments |
| 12/29/2010 | EP2265249A1 Cosmetic compositions comprising exopolysaccharides derived from microbial mats, and use thereof |
| 12/29/2010 | EP2265135A2 Synbiotic mixture |
| 12/29/2010 | EP2265126A1 Methods and compositions for controlled delivery of phytochemical agents |
| 12/29/2010 | EP1692275B1 Method and system for preparing stem cells from fat tissue |
| 12/29/2010 | EP1494705B1 A composition and method for killing of tumours |
| 12/29/2010 | EP1425305B1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses |
| 12/29/2010 | EP1165133B1 Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease |
| 12/29/2010 | CN201683551U Pillow |
| 12/29/2010 | CN1969984B Externally applied medicament for treating acne and allergy |
| 12/29/2010 | CN1948342B HLA-A2 restriction epi polypeptide originated from post selection cancer gene hRabj and its application |
| 12/29/2010 | CN1856504B Anti-infarction molecules |
| 12/29/2010 | CN101932334A Compositions for reducing dental erosion |
| 12/29/2010 | CN101928703A Package and transplant of adipocyte |
| 12/29/2010 | CN101928692A Differentiated cells suitable for human therapy |
| 12/29/2010 | CN101926989A Recombinant attenuated Salmonella typhimurium vector vaccine for expressing JEV (Japanese Encephalitis Virus) immunogenic gene as well as preparation method thereof |
| 12/29/2010 | CN101926978A Medicine composition for promoting bone and bony articulation health |
| 12/29/2010 | CN101926968A Traditional Chinese medicine for treating acquired immune deficiency syndrome |
| 12/29/2010 | CN101926966A Method for preparing cough-relieving and sputum-reducing ginger honey paste |
| 12/29/2010 | CN101926964A 伤愈膏 Injury cream |
| 12/29/2010 | CN101926958A Chinese and Western medicine composition containing carbenoxolone sodium |
| 12/29/2010 | CN101926957A Medicinal composition for treating arthralgia syndrome and preparation method thereof |
| 12/29/2010 | CN101926956A Chinese medicinal powder for treating mazoitis, hyperplasia of mammary glands and breast cancer |
| 12/29/2010 | CN101926955A Medicament for treating stomach illness |
| 12/29/2010 | CN101926954A Clysis decoction for treating chronic colitis |
| 12/29/2010 | CN101926950A Brain-invigorating traditional Chinese medicine composite and preparation method and detection method thereof |
| 12/29/2010 | CN101926946A Drug composition for whitening skin and removing freckle and preparation method thereof |
| 12/29/2010 | CN101926943A Method for preparing burn and scald pain killing band-aid |
| 12/29/2010 | CN101926942A Glucose-lowering health care medicinal tea and preparation method thereof |
| 12/29/2010 | CN101926939A Chinese medicinal preparation for treating rheumatic diseases |
| 12/29/2010 | CN101926938A Drug for curing tinnituscerebri |